Supreme Court lens on stem cell therapy for autism | India News
Hindustan Times
The Supreme Court of India has directed the government to provide details on clinical trials for stem cell therapy for autism, emphasizing the need to regulate the controversial treatment within a research framework. The court previously ruled that such therapy cannot be offered as routine or commercial treatment and must be confined to approved clinical trials. The government and related stakeholders have been asked to report on steps taken to transition existing patients into regulated research settings.
All articles from 15 September 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.